EUVIMEDEUVIMED entdecken
Fallbericht

Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants

André B P van Kuilenburg iD, Marjolein C H Pleunis-van Empel, Rick B Brouwer, Angelique E J Sijben, Daan G Knapen iD, Thijs H Oude Munnink iD, Jelmer J van Zanden, Jenny Janssens-Puister, Doreen Dobritzsch, Rutger Meinsma, Judith Meijer-Jansen, Silvy J M van Dooren und 5 weitere

JCO Precision Oncology · 2024-05 · (8)

DOI: 10.1200/po.23.00599 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCO Precision Oncology, 2024-05. Verfasst von André B P van Kuilenburg und 16 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Laborator…. Hauptthemen laut MEDLINE: Dihydropyrimidine Dehydrogenase Deficiency, Capecitabine, Dihydrouracil Dehydrogenase (NADP), Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A DPD deficiency should be considered in case of severe toxicity even in the absence of common risk variants in DPYD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dihydropyrimidine Dehydrogenase DeficiencyCapecitabineDihydrouracil Dehydrogenase (NADP)Antimetabolites, AntineoplasticHumansMaleFemaleFatal OutcomeMiddle Aged

Substanzen

CapecitabineDihydrouracil Dehydrogenase (NADP)Antimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, Amsterdam, the Netherlands.
  • Medisch Spectrum Twente, Department of Oncology, Enschede, the Netherlands.
  • Department of Clinical Chemistry and Laboratory Medicine, Medisch Spectrum Twente, Medlon BV, Enschede, the Netherlands.
  • Department of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

ORCID-Profile: André B P van Kuilenburg, Daan G Knapen, Thijs H Oude Munnink, Gajja S Salomons, Jan Gerard Maring, Klary E Niezen-Koning

Zitieren

APA

van Kuilenburg, A. B. P., Pleunis-van Empel, M. C. H., Brouwer, R. B., Sijben, A. E. J., Knapen, D. G., Oude Munnink, T. H., van Zanden, J. J., Janssens-Puister, J., Dobritzsch, D., Meinsma, R., Meijer-Jansen, J., van Dooren, S. J. M., Vijzelaar, R., Pop, A., Salomons, G. S., Maring, J. G., & Niezen-Koning, K. E. (2024). Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants. JCO Precision Oncology. https://doi.org/10.1200/po.23.00599

Vancouver

van Kuilenburg ABP, Pleunis-van Empel MCH, Brouwer RB, Sijben AEJ, Knapen DG, Oude Munnink TH, et al. Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants. JCO Precision Oncology. 2024. doi:10.1200/po.23.00599

BibTeX
@article{vanKuilenburg2024,
  author = {van Kuilenburg, André B P and Pleunis-van Empel, Marjolein C H and Brouwer, Rick B and Sijben, Angelique E J and Knapen, Daan G and Oude Munnink, Thijs H and van Zanden, Jelmer J and Janssens-Puister, Jenny and Dobritzsch, Doreen and Meinsma, Rutger and Meijer-Jansen, Judith and van Dooren, Silvy J M and Vijzelaar, Raymon and Pop, Ana and Salomons, Gajja S and Maring, Jan Gerard and Niezen-Koning, Klary E},
  title = {Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants},
  journal = {JCO Precision Oncology},
  year = {2024},
  number = {8},
  doi = {10.1200/po.23.00599}
}
Kostenlos starten →